Skip to main content
Reneo Pharmaceuticals, Inc.
  • Overview
    • Who We Are
      • About Us
      • Our Work
      • Leadership
      • Careers
    • Programs
      • REN001 Overview
      • Pipeline
      • Clinical Trials
      • Presentations and Publications
    • Patients
      • PMMs
      • FAODs
      • McArdle
      • Patient Stories
      • Clinical Research
    • News
    • Investors
      • Corporate Overview
      • News
      • Events & Presentations
      • Stock Information
        • Analyst Coverage
      • Financials & Filings
      • Corporate Governance
        • Leadership Team
        • Board of Directors
        • Committee Composition
        • Documents and Charters
      • Resources
        • Investor FAQs
        • Investor Email Alerts
        • Contact Investor Relations
    • Contact
  • Overview
    • Who We Are
      • About Us
      • Our Work
      • Leadership
      • Careers
    • Programs
      • REN001 Overview
      • Pipeline
      • Clinical Trials
      • Presentations and Publications
    • Patients
      • PMMs
      • FAODs
      • McArdle
      • Patient Stories
      • Clinical Research
    • News
    • Investors
      • Corporate Overview
      • News
      • Events & Presentations
      • Stock Information
        • Analyst Coverage
      • Financials & Filings
      • Corporate Governance
        • Leadership Team
        • Board of Directors
        • Committee Composition
        • Documents and Charters
      • Resources
        • Investor FAQs
        • Investor Email Alerts
        • Contact Investor Relations
    • Contact

Investor FAQs

  • Overview
    • Who We Are
      • About Us
      • Our Work
      • Leadership
      • Careers
    • Programs
      • REN001 Overview
      • Pipeline
      • Clinical Trials
      • Presentations and Publications
    • Patients
      • PMMs
      • FAODs
      • McArdle
      • Patient Stories
      • Clinical Research
    • News
    • Investors
      • Corporate Overview
      • News
      • Events & Presentations
      • Stock Information
        • Analyst Coverage
      • Financials & Filings
      • Corporate Governance
        • Leadership Team
        • Board of Directors
        • Committee Composition
        • Documents and Charters
      • Resources
        • Investor FAQs
        • Investor Email Alerts
        • Contact Investor Relations
    • Contact

IR Contact

For Investor Relations please contact

investors@reneopharma.com


Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Reneo Pharmaceuticals, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Reneo Pharmaceuticals, Inc. to send you the requested Investor Email Alert updates.

* Required

*
*





Unsubscribe

Email Alert Sign Up Confirmation

Reneo Pharmaceuticals
  • Company
  • Who We Are
  • Programs
  • Patients
  • News
  • Investors
  • Contact
  • Links
  • US Privacy Policy
  • EU Privacy Policy
© Copyright – Reneo Pharmaceuticals, Inc.
Powered By Q4 Inc. 5.112.0.8 (opens in new window)